RiverNorth Opportunities Fund issued 3.36 million new shares at $10.49 each, about 90% of its net asset value, raising approximately $35.2 million through a 1-for-3 rights offering. Only around 37% of the new shares were subscribed, which limited the net asset value dilution to about -1.2%, better than the estimated -2.5% if fully subscribed. The offering had no sales load and incurred minimal expenses of roughly $272,000. Investors who executed a sell-and-rebuy around the ex-rights date gained about 5.2% in free shares, though over half of that gain was due to a decline in the fund's NAV rather than the offering itself. This capital raise provides the fund with additional resources while minimizing dilution for existing shareholders.
RiverNorth Opportunities Fund's rights offering results provide context for financial markets. For readers following Financials-sector US stocks on Pluang, here is the market snapshot as of Oct 06, 2026 17:12 WIB: out of 85 priced stocks, 67 rose and 14 fell. Barclays PLC (BCS) traded at USD 23.97 with a 1-day change of +1.61% and a typical hold time of 62 days, showing 100% sell order activity. Deutsche Bank AG (DB) was priced at USD 35.49, up +1.49%, with a longer hold time of 79 days and 100% buy order activity. HSBC Holdings plc (HSBC) stood at USD 97.99, gaining +1.35%, with a shorter hold time of 36 days and a near-even split of buy/sell orders (54% buy).
Morgan Stanley analyst Bob Huang lowered American International Group's (AIG) price target to $80 from $81, with the stock trading around $76, indicating potential upside. AIG is set to report its Q3 2026 earnings on November 3, with investors focuse...
Vertiv Holdings, a maker of power and cooling equipment for data centers, faces mixed analyst opinions with GLJ Research rating it a "Sell" and BMO Capital giving an "Outperform" rating. Despite a recent stock pullback, the company reported a 241% in...
Apogee Enterprises reported strong fiscal Q2 results with adjusted earnings of $1.17 per share, nearly double the estimated $0.59, and revenue of $391.14 million, surpassing expectations of $362.6 million. This marks a continued trend of beating esti...
McKesson received a bullish price target of $977 from Morgan Stanley, suggesting a 6.7% upside from its current price of $915.45. The company agreed to acquire Option Care Health for $32.05 per share, valuing the deal at approximately $5.8 billion in...
Ameriprise Financial has authorized an additional $5.5 billion for share repurchases through September 2028, supported by $2.1 billion in excess capital and $2.8 billion in liquidity. The company returned $1.9 billion to shareholders in H1 2026, incl...
